Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEACON-IPF: bexotegrast in idiopathic pulmonary fibrosis
jRCT2051240025Completed
- Sponsor
- Pliant Therapeutics
- Start
- Nov 2024
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of bexotegrast in idiopathic pulmonary fibrosis (IPF) (3 arms), sponsored by Pliant Therapeutics. Primary endpoint: Change in FVC at Week 52. Started Nov 2024; status: completed.
02
Drugs
bexotegrast
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on jRCT2051240025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2051240025.